Global Superdisintegrants Market to Reach US$ 590.1 Million by 2028, Impelled by Significant Growth in Pharmaceutical Industry

June 22, 2022 | Healthcare

According to the latest report by IMARC Group, titled “Superdisintegrants Market: Global Industry, Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global superdisintegrants market reached a value of US$ 388.8 Million in 2022. Superdisintegrants are modified disintegrants added to the drug formulation to improve the efficacy of dosages. This is achieved by reducing the disintegrating time of tablet or capsule content into smaller particles, which, in turn, enhances the drug dissolution rate. Superdisintegrants are commonly available in natural and synthetic variants. They consist of fragments of disintegrated parts of tablet components such as insoluble coating of the tablets or capsule shells or any melted fatty substance. Superdisintegrants exhibit various properties, including good molding, hydration capacity, and flow characteristics, which aids in increasing the absorption of the drug and the solubility of active pharmaceutical ingredients (APIs) in the body.

Global Superdisintegrants Market Trends:

The rising geriatric population and the increasing instances of chronic diseases across the globe are creating a positive outlook for the market. In line with this, the growing popularity of orally disintegrating tablets (ODTs) in the pharmaceutical and nutraceutical industry to treat patients with dysphagia and various other conditions is favoring the market growth. Apart from this, continuous product innovations, such as the introduction of superdisintegrants with higher compatibility, improved bioavailability, and efficient compressibility, are augmenting the market growth. Additionally, the widespread product adoption to manufacture antipsychotics, antidepressants, antimigraine, and sedatives is positively impacting the market growth. Other factors, including the increasing acceptability of generic drugs, extensive research and development (R&D) activities, and the implementation of various government initiatives promoting the use of safer alternatives in the pharmaceutical industry, are anticipated to drive the market toward growth. On account of the aforementioned factors, the market value is expected to reach US$ 590.1 Million by 2028, exhibiting a CAGR of 6.4% during 2023-2028.

Market Summary

On the basis of the product, the market has been divided into croscarmellose sodium, crospovidone, sodium starch glycolate, ion exchange resin, modified cellulose, and others.
Based on the type, the market has been classified into natural superdisintegrant, synthetic superdisintegrant, and others.
Based on the dosage form, the market has been bifurcated into tablets and capsules, and mouth-dissolving films.
On the basis of the therapeutic areas, the market has been divided into gastrointestinal, cardiovascular, neurology, oncology, hematology, and others.
Based on the region, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and Others) Latin America (Brazil, Mexico and Others), Middle East and Africa.
The competitive landscape of the industry has also been examined in the report. Some of the key players include Asahi Kasei Corporation, Ashland Global Specialty Chemicals Inc., Avantor Inc., BASF SE, Corel Pharma Chem, DFE Pharma GmbH & Co. KG, DuPont de Nemours Inc., JRS Pharma GmbH & Co. KG, Merck KGaA, Nippon Soda Co. Ltd., Roquette Frères and Sigachi Industries Limited.

Report Scope:

Report Features	Details
Base Year of the Analysis	2022
Historical Period	2017-2022
Forecast Period	2023-2028
Units	US$ Million
Segment Coverage	Product, Type, Dosage Form, Therapeutic Areas, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Asahi Kasei Corporation, Ashland Global Specialty Chemicals Inc., Avantor Inc., BASF SE, Corel Pharma Chem, DFE Pharma GmbH & Co. KG, DuPont de Nemours Inc., JRS Pharma GmbH & Co. KG, Merck KGaA, Nippon Soda Co. Ltd., Roquette Frères and Sigachi Industries Limited
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Superdisintegrants Market to Reach US$ 590.1 Million by 2028, Impelled by Significant Growth in Pharmaceutical Industry

Purchase options Year End sale

Single User License ~~$2499~~ $2249
Five User License ~~$3499~~ $2974
Corporate License ~~$4499~~ $3599

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.